Abstract
A 57-year-old man was admitted to our hospital with a complaint of perineal pain. He was diagnosed as advanced rectal cancer with an invasion of prostate, and we conducted neoadjuvant capecitabine, oxaliplatin, bevacizumab and radiation therapy. After chemoradiation therapy, the tumor regressed to an ulcerative lesion without invasion of the prostate. Abdominoperineal resection was then performed without radical resection. The tumor regressed to an ulcer and only a few cancer cells were detected in the submucosal layer pathologically.
MeSH terms
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bevacizumab
-
Capecitabine
-
Deoxycytidine / administration & dosage
-
Deoxycytidine / analogs & derivatives*
-
Deoxycytidine / therapeutic use
-
Fluorouracil / administration & dosage
-
Fluorouracil / analogs & derivatives*
-
Fluorouracil / therapeutic use
-
Humans
-
Male
-
Middle Aged
-
Neoadjuvant Therapy*
-
Neoplasm Invasiveness
-
Organoplatinum Compounds / administration & dosage
-
Organoplatinum Compounds / therapeutic use*
-
Oxaliplatin
-
Rectal Neoplasms / drug therapy*
-
Rectal Neoplasms / pathology
-
Rectal Neoplasms / radiotherapy
-
Rectal Neoplasms / surgery
-
Tomography, X-Ray Computed
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Organoplatinum Compounds
-
Oxaliplatin
-
Deoxycytidine
-
Bevacizumab
-
Capecitabine
-
Fluorouracil